Sharemaestro company-news research for Amesite Operating Co (AMST), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Provisional evidence
Company news sentiment
Latest AMST news and sentiment
Amesite Operating Co
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
Current company news
Early balanced news score
11 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone63/100
→
Published 30-day score50/100
Latest source headline
Losh’s trust acquires 14,646 stock units instead of cash director pay at Amesite (AMST).
Stock Titan · 03 Oct 2026 19:00
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
11 current stories are mapped specifically to AMST.
The score uses 3 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.035.
Confidence is 17/100, below the threshold for a firm score.
50/100
News scoreEarly balanced news score
17/100
Confidencethin evidence
100%/100
Company news11 company stories
95/100
Story agreement5/100 difference
News history
Daily score and story count over 30 days
17 Sep02 Oct16 Oct
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence1
0.035 after freshness weightingSource breadth60
3 independent publishersCompany relevance100
share tied directly to this companyFreshness8
recency-weighted evidenceAgreement95
how closely stories agreePublisher mix65
less reliance on one publisherPrice and news history
Weekly price and news-score history
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
26 completed price weeks16 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
17 Apr14 Jul09 Oct
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
09 Oct 202651USD 0.8764-6.8%
02 Oct 202652USD 0.94-9.6%
25 Sep 202653USD 1.04-3.7%
18 Sep 202650USD 1.08+4.3%
11 Sep 202650USD 1.035-3.3%
04 Sep 202650USD 1.07+0.9%
28 Aug 202650USD 1.06-0.9%
21 Aug 202650USD 1.07+10.0%
Provisional evidence
News subjects
What is shaping the score
Earnings624 stories · 36%
Market update504 stories · 36%
Balance sheet503 stories · 27%
Source mix
Where the evidence comes from
Stock Titan514 stories · 36%
GuruFocus681 stories · 9%
TradingView621 stories · 9%
Bitget551 stories · 9%
Kalkine Media501 stories · 9%
Investing.com501 stories · 9%
Quiver Quantitative501 stories · 9%
Recurring subjects
Subjects appearing most often
Technology9Earnings7Finance6Life Sciences5Financial Markets5
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
25 Jun50 neutral16 Oct 04:06
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 16 Oct 04:06 | 50 | -1 | 17/100 (-6) | 11 (-2) | Provisional |
| 03 Oct 23:59 | 51 | -1 | 23/100 (-1) | 13 (+1) | Provisional |
| 02 Oct 23:59 | 52 | -2 | 24/100 (-15) | 12 (+2) | Provisional |
| 24 Sep 23:59 | 54 | +4 | 39/100 (+39) | 10 (+6) | Provisional |
| 18 Sep 23:59 | 50 | +0 | 0/100 (0) | 4 (+1) | Insufficient |
| 11 Sep 23:59 | 50 | +0 | 0/100 (0) | 3 (+1) | Insufficient |
| 09 Sep 23:59 | 50 | +0 | 0/100 (-16) | 2 (-8) | Insufficient |
| 23 Aug 23:59 | 50 | -1 | 16/100 (-11) | 10 (-9) | Provisional |
Evidence behind the direction
What drives this reading?
Shares of weighted directional evidence in 11 retained current headlines. These weights already account for freshness, relevance and publisher limits; they are not additive points of the published score.
Which subjects lean each way
A subject can carry both supportive and cautious news.
SubjectCautious ← 0 → Constructive
Earnings3 stories
0.0%100.0%
Each side uses the same scale: 0–100.0% of the retained directional evidence.
Where the influence comes from
42.3%largest publisher shareA concentrated reading can depend heavily on one publisher.
Publisher groups follow the scoring rules. Company disclosures share one group; syndicated stories are consolidated before weighting.
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
—Unscored
Balance sheetNot used in direction
Losh’s trust acquires 14,646 stock units instead of cash director pay at Amesite (AMST).
Amesite Inc. director J. Michael Losh’s Irrevocable Qualified Annuity Trust #7 acquired 14,646 restricted stock units on September 30, 2026. These units were received as deferred stock compensation for director services, in lieu of cash. The units represent a contingent right to receive o…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite Inc. director J. Michael Losh’s Irrevocable Qualified Annuity Trust #7 acquired 14,646 restricted stock units on September 30, 2026. These units were received as deferred stock compensation for director services, in lieu of cash. The units represent a contingent right to receive one AMST common share or its cash equivalent, and will be issued upon completion of board service or a change in control.
- Published
- 03 Oct 2026 19:00
- News subject
- Balance sheet
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 12.4d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
FinanceFinancial Markets
—Unscored
Balance sheetNot used in direction
Amesite (AMST) director George Parmer acquires 12,121 stock units in lieu of cash compensation.
Amesite Inc. director George Parmer acquired 12,121 restricted stock units on September 30, 2026, as deferred compensation for his services. These units, which represent a contingent right to receive AMST common stock or its cash equivalent, will be issued upon the completion of his board…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite Inc. director George Parmer acquired 12,121 restricted stock units on September 30, 2026, as deferred compensation for his services. These units, which represent a contingent right to receive AMST common stock or its cash equivalent, will be issued upon the completion of his board service or a change in control. Following this transaction, Parmer's reported resulting position in restricted stock units is 89,031.
- Published
- 02 Oct 2026 20:00
- News subject
- Balance sheet
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 13.3d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
FinanceTechnology
—Unscored
Balance sheetNot used in direction
Instead of cash, director Omenn’s trust acquires 12,121 stock units in Amesite (AMST).
Amesite Inc. director Gilbert S. Omenn's revocable trust acquired 12,121 restricted stock units (RSUs) on September 30, 2026, as deferred compensation for board service. These RSUs, which represent a contingent right to receive common shares or cash, resulted in a reported holding of 95,9…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite Inc. director Gilbert S. Omenn's revocable trust acquired 12,121 restricted stock units (RSUs) on September 30, 2026, as deferred compensation for board service. These RSUs, which represent a contingent right to receive common shares or cash, resulted in a reported holding of 95,927 RSUs for the trust. The acquisition was detailed in a Form 4 SEC filing, indicating a neutral impact and sentiment.
- Published
- 02 Oct 2026 20:00
- News subject
- Balance sheet
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 13.3d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
FinanceFinancial MarketsTechnology
62/100 tone
Amesite Inc. (AMST) reported its fiscal year 2026 financial results, with revenue increasing significantly to $364,777, a 230.3% year-over-year change. The company also narrowed its net loss to $(3,095,838) and improved diluted EPS to $(0.63) compared to the previous year. This growth was…
32.8% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Amesite Inc. (AMST) reported its fiscal year 2026 financial results, with revenue increasing significantly to $364,777, a 230.3% year-over-year change. The company also narrowed its net loss to $(3,095,838) and improved diluted EPS to $(0.63) compared to the previous year. This growth was primarily driven by B2B license fees for its NurseMagic™ product, as the company strategically shifted its focus from higher education to healthcare and AI feature development, while also implementing cost-saving measures.
- Published
- 24 Sep 2026 14:54
- News subject
- Earnings
- Why this score
- Improving financial comparison, Loss narrowed
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 42/100
- 30-day weight
- 32.8% of directional evidence · 21.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsFinanceLife SciencesTechnology
57/100 tone
Amesite Inc. (AMST) reported an increase in fiscal 2026 revenue to $364,777, up from $110,459 in 2025, driven by its NurseMagic™ app, which secured a significant 2,700-patient enterprise deployment. Despite this revenue growth and a narrowed net loss, the company issued a "going concern" …
24.9% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Amesite Inc. (AMST) reported an increase in fiscal 2026 revenue to $364,777, up from $110,459 in 2025, driven by its NurseMagic™ app, which secured a significant 2,700-patient enterprise deployment. Despite this revenue growth and a narrowed net loss, the company issued a "going concern" warning, indicating that current cash and financing plans may not cover operations for the next 12 months. The annual report emphasizes the company's strategic shift to AI-powered healthcare solutions and highlights the risks associated with regulatory compliance, market competition, and the need for additional funding.
- Published
- 24 Sep 2026 14:54
- News subject
- Earnings
- Why this score
- Improving financial comparison
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 36/100
- 30-day weight
- 24.9% of directional evidence · 21.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsLife SciencesTechnology
—Unscored
EarningsNot used in direction
Amesite signs NurseMagic Enterprise deal under USD 1,099-a-month minimum pricing model
Amesite announced a new NurseMagic Enterprise customer for its NurseMagic platform, targeting post-acute care providers. The deal is structured under a minimum enterprise pricing model of USD 1,099 per month for organizations with up to 1,000 patients, secured through a 12-month contract.…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite announced a new NurseMagic Enterprise customer for its NurseMagic platform, targeting post-acute care providers. The deal is structured under a minimum enterprise pricing model of USD 1,099 per month for organizations with up to 1,000 patients, secured through a 12-month contract. This pricing model is expected to yield approximately 85% gross margin, supporting scalable revenue growth for Amesite.
- Published
- 24 Sep 2026 14:54
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 21.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsLife SciencesTechnology
—Unscored
Market updateNot used in direction
Amesite Inc. Submits 2026 Annual Report Detailing Shares, Market Value, and Operational Risks
Amesite Inc. (NASDAQ:AMST) filed its 2026 Annual Report on Form 10-K, disclosing 6,549,851 outstanding common shares and a market value for non-affiliates of approximately $8,995,000 as of December 31, 2025. The report also identified the company as a non-accelerated filer and a smaller r…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite Inc. (NASDAQ:AMST) filed its 2026 Annual Report on Form 10-K, disclosing 6,549,851 outstanding common shares and a market value for non-affiliates of approximately $8,995,000 as of December 31, 2025. The report also identified the company as a non-accelerated filer and a smaller reporting company, highlighting the ability to continue as a going concern as a significant risk factor. Amesite's primary product is NurseMagic, an AI-driven platform.
- Published
- 24 Sep 2026 14:54
- News subject
- Market update
- Why this score
- Balance-sheet distress
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 21.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsFinanceFinancial MarketsTechnology
—Unscored
Market updateNot used in direction
Amesite wins enterprise customer with new pricing model
Amesite Inc. (NASDAQ:AMST) has secured an enterprise customer for its NurseMagic documentation platform, utilizing a new minimum enterprise pricing model set at $1,099 per month for organizations with up to 1,000 patients. This strategy aims to serve smaller operators profitably while inc…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite Inc. (NASDAQ:AMST) has secured an enterprise customer for its NurseMagic documentation platform, utilizing a new minimum enterprise pricing model set at $1,099 per month for organizations with up to 1,000 patients. This strategy aims to serve smaller operators profitably while increasing revenue potential with larger organizations, leading to an estimated 85% gross margin on annual agreements at this level. The company reported a 2.4x sequential quarterly revenue increase and 63% revenue growth from NurseMagic Enterprise, highlighting the success of its AI-based healthcare documentation technology.
- Published
- 24 Sep 2026 14:54
- News subject
- Market update
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 21.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 2 consolidated
EarningsLife SciencesTechnology
—Unscored
Market updateNot used in direction
Amesite Announces New NurseMagic Enterprise Sales Win, Validating Minimum Pricing Model for Post-Acute Care Organizations
Amesite Inc. announced a new enterprise sales win for its NurseMagic® platform, validating a minimum pricing model for post-acute care organizations. This model, set at $1,099 per month for up to 1,000 patients, aims for significant gross margins and scalable revenue growth without requir…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite Inc. announced a new enterprise sales win for its NurseMagic® platform, validating a minimum pricing model for post-acute care organizations. This model, set at $1,099 per month for up to 1,000 patients, aims for significant gross margins and scalable revenue growth without requiring customers to replace existing Electronic Medical Records (EMRs). The company highlights previous successes, including substantial revenue increases, and focuses on expanding its market reach through this flexible pricing structure.
- Published
- 24 Sep 2026 14:54
- News subject
- Market update
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 21.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 3 consolidated
EarningsLife SciencesTechnology
68/100 tone
Amesite Inc (NASDAQ: AMST) is highlighted as potentially undervalued by 57.4% according to GuruFocus's GF Value™ despite challenging Price-to-Sales metrics and ongoing profitability issues. The company's recent strategic sales win and minimum enterprise pricing model aim to enhance revenu…
42.3% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
Amesite Inc (NASDAQ: AMST) is highlighted as potentially undervalued by 57.4% according to GuruFocus's GF Value™ despite challenging Price-to-Sales metrics and ongoing profitability issues. The company's recent strategic sales win and minimum enterprise pricing model aim to enhance revenue growth, while strong insider buying and guru ownership signal confidence in its future. AMST has strong financial strength with no debt but struggles with low profitability and growth.
- Published
- 24 Sep 2026 05:51
- News subject
- Earnings
- Why this score
- Positive valuation view, Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 50/100
- 30-day weight
- 42.3% of directional evidence · 21.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
EarningsFinancial MarketsTechnology
—Unscored
Market updateNot used in direction
Amesite Sets Dec. 10 Annual Meeting, a Shift of Over 30 Days
Amesite Inc. (Nasdaq: AMST) has announced that its annual stockholders' meeting will be held on December 10, 2026, a significant change from its previous July 13, 2026 date. Due to this shift, the company has set an accelerated deadline of September 27, 2026, for stockholders to submit pr…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Amesite Inc. (Nasdaq: AMST) has announced that its annual stockholders' meeting will be held on December 10, 2026, a significant change from its previous July 13, 2026 date. Due to this shift, the company has set an accelerated deadline of September 27, 2026, for stockholders to submit proposals or director nominations. This condensed timeline limits the practical opportunity for shareholders to participate in the nomination process.
- Published
- 18 Sep 2026 06:26
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 27.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
FinanceFinancial Markets
Earlier company news
AMST news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 24 older AMST headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to AMST, but the headline and available text are not mainly about Amesite Operating Co. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
23Aug 2026
Provider mentionNot included in score
Hopeful Week For Insiders Who Bought US$600.0k Of Amesite Stock
Insiders at Amesite Inc. (NASDAQ:AMST) recently bought US$600.0k worth of stock, which has seen some recovery with a 10% gain last week, though the purchases are still at a loss. The largest individual purchase was US$350k by Independent Director George Parmer at a price higher than the c…
Article detailsWhy it was excluded
Insiders at Amesite Inc. (NASDAQ:AMST) recently bought US$600.0k worth of stock, which has seen some recovery with a 10% gain last week, though the purchases are still at a loss. The largest individual purchase was US$350k by Independent Director George Parmer at a price higher than the current market value. Insiders collectively own a significant 47% of the company, suggesting strong alignment with shareholder interests.
- Published
- 23 Aug 2026 18:53
- Provider record
- alphavantage, google_news
- Use in sentiment
- Not scored
- Reason
- Company is not the main subject
- Duplicates
- 1 consolidated
FinanceFinancial MarketsTechnology
23Aug 2026
Provider mentionNot included in score
Hopeful Week For Insiders Who Bought US$600.0k Of Amesite Stock
Insiders at Amesite Inc. (NASDAQ:AMST) recently bought US$600.0k worth of stock, which has seen some recovery with a 10% gain last week, though the purchases are still at a loss. The largest individual purchase was US$350k by Independent Director George Parmer at a price higher than the c…
Article detailsWhy it was excluded
Insiders at Amesite Inc. (NASDAQ:AMST) recently bought US$600.0k worth of stock, which has seen some recovery with a 10% gain last week, though the purchases are still at a loss. The largest individual purchase was US$350k by Independent Director George Parmer at a price higher than the current market value. Insiders collectively own a significant 47% of the company, suggesting strong alignment with shareholder interests.
- Published
- 23 Aug 2026 13:15
- Provider record
- alphavantage
- Use in sentiment
- Not scored
- Reason
- Company is not the main subject
- Duplicates
- 3 consolidated
FinanceFinancial MarketsTechnology
26Jul 2026
Provider mentionNot included in score
TradingKey
This article provides a detailed quarterly and annual income statement for Amesite Inc. (AMST), detailing revenue, operating expenses, profits, and earnings per share. It also includes key financial figures for recent periods and FAQs on how to interpret the income statement data on Tradi…
Article detailsWhy it was excluded
This article provides a detailed quarterly and annual income statement for Amesite Inc. (AMST), detailing revenue, operating expenses, profits, and earnings per share. It also includes key financial figures for recent periods and FAQs on how to interpret the income statement data on TradingKey. The company reported a stock price of $0.990 with a 3.99% increase and a market capitalization loss.
- Published
- 26 Jul 2026 09:40
- Provider record
- alphavantage
- Use in sentiment
- Not scored
- Reason
- Company is not the main subject
- Duplicates
- 1 consolidated
EarningsFinancial Markets
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme. This is a rule-based evidence measure, not a calibrated probability.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.